AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Quetiapine Fumarate Immediate Release (IR) Versus Extended Release (XR) Dose Escalation Comparison
- First Posted Date
- 2008-06-20
- Last Posted Date
- 2009-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 63
- Registration Number
- NCT00702676
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
National Survey on Dyslipidemic Patients
Completed
- Conditions
- Dyslipidemia
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 3655
- Registration Number
- NCT00701402
- Locations
- 🇫🇷
Research Site, Yquelon, France
Cross-over Study to Investigate Retinal Function Following Administration of a Single Dose of AZD9056
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 12
- Registration Number
- NCT00700986
- Locations
- 🇬🇧
Research Site, Nottingham, Nottinghamshire, United Kingdom
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
- First Posted Date
- 2008-06-19
- Last Posted Date
- 2015-04-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 80
- Registration Number
- NCT00701935
- Locations
- 🇨🇦
Research Site, Quebec, Canada
National Survey on Coronary Patients and Heart Failure Performed in 2 Patient Groups
Completed
- Conditions
- Coronary PatientsHeart Failure
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2009-08-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1650
- Registration Number
- NCT00699959
- Locations
- 🇫🇷
Research Site, Wattrelos Cedex, France
Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients
Completed
- Conditions
- ComplianceGastroprotector TherapyRisk Factors
- First Posted Date
- 2008-06-18
- Last Posted Date
- 2010-12-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2000
- Registration Number
- NCT00699725
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 568
- Registration Number
- NCT00698932
- Locations
- 🇵🇭
Research Site, Quezon City, Philippines
Observational Study on Costs and Caregiver Burden in Alzheimer's Disease
Completed
- Conditions
- Alzheimer's Disease
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2009-02-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2400
- Registration Number
- NCT00698165
- Locations
- 🇬🇧
Research Site, Uckfield, United Kingdom
Single and Multiple Ascending Doses of AZD1981 in Japan
- First Posted Date
- 2008-06-17
- Last Posted Date
- 2010-12-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 47
- Registration Number
- NCT00698282
- Locations
- 🇬🇧
Research Site, Berkshire, United Kingdom
Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study
Completed
- Conditions
- GERD
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2009-02-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 300
- Registration Number
- NCT00697008
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
© Copyright 2025. All Rights Reserved by MedPath